RxDoctor Payments Data

Gregory Jicha, MD

Neurology · Lexington, KYNPI 1619073202

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,000 of the $1,384 with a category attached, or 72.2%. Every reported general payment came from a single manufacturer, Eisai Inc.. That places this record below the midpoint for neurology clinicians in KY, where the typical reported total is $1,714.

$1,384in general payments, 2019–2025

Across 12 payments — averaging $115.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$1K
$7,096,534in research payments, 2019–2025

Across 721 payments — averaging $9842.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eisai Inc.$3.9M
  • AbbVie$1.2M
  • Eli Lilly$904K
  • Novartis$842K
  • Novo Nordisk AS$177K
  • Alnylam Pharmaceuticals Inc.$104K
  • plus $29K from 2 others

What the payments were for

  • Travel & lodging$1,00072%
  • Food & beverage$38428%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eisai Inc.12$1,384

How this compares

$1,384 in reported general payments places this provider in the 45th percentile of 210 neurology providers in Kentucky.

See all neurology providers in Kentucky

Medicare billing

Part B allowed, 2024
$39,434
Medicare patients
182
Services billed
327

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rivastigmine74$19,728
Memantine Hcl354$10,292
Memantine Hcl ErMemantine Hcl32$5,491
Donepezil Hcl371$3,389
Mirtazapine85$1,020
Escitalopram Oxalate92$777
Lamotrigine56$668
Quetiapine Fumarate42$568
Divalproex Sodium ErDivalproex Sodium11$454
Primidone21$276
Levetiracetam33$275
Duloxetine Hcl23$270
Carbidopa-LevodopaCarbidopa/Levodopa11$238
Trazodone Hcl29$227
Gabapentin14$188

Paid to pharmacies, not to this prescriber.

Other neurology in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →